中华内分泌代谢杂志
中華內分泌代謝雜誌
중화내분비대사잡지
CHINESE JOURNAL OF ENDOCRINOLOGY AND METABOLISM
2014年
9期
800-803
,共4页
糖尿病,2型%低中比例%预混胰岛素类似物
糖尿病,2型%低中比例%預混胰島素類似物
당뇨병,2형%저중비례%예혼이도소유사물
Diabetes mellitus,type 2%Low-and mid-mixture%Premixed insulin analogues
预混胰岛素是目前中国应用最广泛的胰岛素起始方案.预混胰岛素类似物可依据基础-餐时部分比例不同分为低预混与中预混两种.前者目前多用于口服降糖药物失效后患者的胰岛素起始治疗方案,而后者目前多被用于每日一次或二次胰岛素治疗方案下血糖控制欠佳患者的胰岛素简约强化治疗方案.
預混胰島素是目前中國應用最廣汎的胰島素起始方案.預混胰島素類似物可依據基礎-餐時部分比例不同分為低預混與中預混兩種.前者目前多用于口服降糖藥物失效後患者的胰島素起始治療方案,而後者目前多被用于每日一次或二次胰島素治療方案下血糖控製欠佳患者的胰島素簡約彊化治療方案.
예혼이도소시목전중국응용최엄범적이도소기시방안.예혼이도소유사물가의거기출-찬시부분비례불동분위저예혼여중예혼량충.전자목전다용우구복강당약물실효후환자적이도소기시치료방안,이후자목전다피용우매일일차혹이차이도소치료방안하혈당공제흠가환자적이도소간약강화치료방안.
Premixed insulin is currently the most popular insulin starter in China.According to the different ratios of basal and prandial components,premixed insulin analogues could be classified into low-and midmixtures.The former is now mainly used as insulin starter in the patients with type 2 diabetes mellitus after the failure of monotherapy or combination with oral antidiabetic drugs,while the later is usually used as simplified intensive insulin treatment in patients with type 2 diabetes mellitus inadequately controlled on insulin once-or twice-daily.
